Galectin Therapeutics GALT Estimates

NASDAQ GALT
$3.91 -0.02 (-0.51%)
At close: Sep 29, 2026 · 4:00 PM EDT
Analyst Estimates

Galectin Therapeutics Inc Annual Revenue Estimates

Periods 9
Next Period 2021
Consensus 0.00

Analysts expect Galectin Therapeutics Inc to report revenue of 0.00 for 2021, against a range of 0.00 to 0.00. The most recent reported year, 2025, came in at 0.00.

Metric 202120222023202420252026202720282029
Reported (Actual) --0.00
High Estimate 0.000.000.00
Low Estimate 0.000.000.00
Consensus Estimate 0.000.000.00
Analyst Estimates

Galectin Therapeutics Inc Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 26
Consensus -0.05

Analysts expect Galectin Therapeutics Inc to report earnings per share of -0.05 for Q3 26, against a range of -0.05 to -0.05. The most recent reported quarter, Q2 26, came in at -0.14, a 55.6% miss against the -0.09 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.18-0.19-0.15-0.12-0.13-0.08-0.08-0.14--------
High Estimate -0.19-0.16-0.19-0.16-0.10-0.09-0.05-0.08-0.05-0.05-0.05-0.09-0.04-0.03-0.19-0.31
Low Estimate -0.21-0.18-0.23-0.18-0.12-0.09-0.07-0.10-0.05-0.05-0.05-0.11-0.04-0.03-0.21-0.35
Consensus Estimate -0.20-0.17-0.21-0.17-0.11-0.09-0.06-0.09-0.05-0.05-0.05-0.10-0.04-0.03-0.20-0.33

Galectin Therapeutics Inc Estimates API

Pull Wall Street consensus for Galectin Therapeutics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=GALT&mode=revenue&api_key=YOUR_API_KEY